<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Intern Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Intern. Med</journal-id>
      <journal-id journal-id-type="doi">10.2169/internalmedicine.56.7349</journal-id>
      <journal-title-group>
        <journal-title>Internal Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0918-2918</issn>
      <issn pub-type="epub">1349-7235</issn>
      <publisher>
        <publisher-name>The Japanese Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28090054</article-id>
      <article-id pub-id-type="pmc">5337469</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hemoglobin Kansas as a Rare Cause of Cyanosis: A Case Report and Review of the Literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nagayama</surname>
            <given-names>Yoshikuni</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoshida</surname>
            <given-names>Minoru</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kohyama</surname>
            <given-names>Tadashi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsui</surname>
            <given-names>Katsuyuki</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Department of Internal Medicine IV, Teikyo University School of Medicine, University Hospital, Mizonokuchi, Japan</aff>
      </contrib-group>
      <author-notes>
        <fn>
          <p>Correspondence to Dr.&#x3000;Yoshikuni Nagayama, <email>ynaga1147@hotmail.co.jp</email></p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <volume>56</volume>
      <issue>2</issue>
      <fpage>207</fpage>
      <lpage>209</lpage>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p><!--CREATIVE COMMONS-->The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Hemoglobin (Hb) Kansas is an inherited Hb variant with a low oxygen affinity that is associated with low oxygen saturation on pulse oximetry (SpO<sub>2</sub>). It leads to asymptomatic cyanosis. Patients with Hb Kansas do not require any specific treatment and the prognosis is good. In patients with unexplained cyanosis, we should thus consider Hb variants, including Hb Kansas and avoid unnecessary investigations and managements. We herein report the case of 65-year-old woman with Hb Kansas and review five other cases (three lineages) that have been reported in Japan. </p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>hemoglobin Kansas</kwd>
        <kwd>hemoglobin variants</kwd>
        <kwd>oxygen affinity</kwd>
        <kwd>cyanosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>More than 1,000 Hb variants have been identified (<xref rid="B1" ref-type="bibr">1</xref>). Abnormal oxygen saturation is not detected by pulse oximetry (SpO<sub>2</sub>) in the majority of Hb variants. However, some patients inherit an Hb variant with a low oxygen affinity that displays low SpO<sub>2</sub> and arterial oxygen saturation (SaO<sub>2</sub>) (<xref rid="B2" ref-type="bibr">2</xref>). Hb Kansas was first reported in 1961 as an Hb variant that displays a very low oxygen affinity (<xref rid="B3" ref-type="bibr">3</xref>). The Hb molecule consists of two &#x3B2;-globin subunits and two &#x3B1;-globin subunits, which maintain the equilibrium between the relaxed state (R), with a high oxygen affinity and the tense state (T), with a low oxygen affinity. Hb Kansas has an AAC to ACC mutation at codon 102 of the &#x3B2;-globin gene, which results in an asparagine (Asn) to threonine (Thr) substitution.</p>
      <p>The binding between &#x3B2;102 Asn and &#x3B1; 94 Asp (aspartic acid) is imperative for the stabilization of R; however, it is impossible for &#x3B2;102 Thr to bind to &#x3B1; 94 Asp. The substitution pushes the equilibrium toward T (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>). Thus, patients with Hb Kansas present cyanosis; however, they are otherwise asymptomatic and do not require any specific treatment.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>A 65-year-old woman was referred to our hospital for renal dysfunction. She had a history of hypertension and hypercholesterolemia. Seven days prior to her admission she had been diagnosed with a facial herpes zoster infection, which was treated with valaciclovir and non-steroidal anti-inflammatory drugs. She subsequently experienced a loss of appetite. There were no remarkable symptoms with the exception of cyanosis of the face, lips and nail beds. Her SpO<sub>2</sub> was 70% on room air, despite the SpO<sub>2</sub> being tested using different oximeter probes on different fingers. Her complete blood counts were normal (hemoglobin (Hb), 13.9 g/dL; hematocrit, 41.6%; mean corpuscular volume, 89.5 fL; reticulocyte count, 1.1%; white blood cell count, 5,160/&#x3BC;L and platelet count 23.3&#xD7;10<sup>4</sup>/&#x3BC;L). There was no evidence of hemolysis. An arterial blood gas analysis (room air) showed that the arterial partial pressure of oxygen (PaO<sub>2</sub>) was 88.7 mmHg, with an SaO<sub>2</sub> value of 58.1%. Her carboxyhemoglobin and methemoglobin levels were both negligible. A urinalysis showed a pH of 5.0, a specific gravity of 1.013, (&#xB1;) protein and (&#xB1;) blood (by dipstick), and negligible casts. The urine sodium and creatinine concentrations were 21 mEq/L and 221 mg/dL, respectively. Moreover, the following values were observed: albumin, 4.4 g/dL; aspartate aminotransferase, 17 U/L; lactate dehydrogenase, 259 U/L; blood urea nitrogen, 39 mg/dL; creatinine, 3.0 mg/dL; uric acid, 8.6 mg/dL; creatine kinase, 137 U/L; sodium, 140 mEq/L; potassium, 4.3 mEq/L; glucose, 128 mg/dL and C-reactive protein, 0.5 mg/dL. Computed tomography revealed normal kidney conformation, no pneumonia and no pulmonary edema. Sufficient fluid replacement rapidly improved her renal function, with her serum creatinine level reaching 0.74 mg/dL; after which the patient recovered. Her renal dysfunction was mainly caused by pre-renal factors.</p>
      <p>However, her SpO<sub>2</sub> value remained low. We investigated the cause of the unexpectedly low SpO<sub>2</sub>. Ultrasound cardiography showed almost normal findings and no shunt flow. A respiratory functional test was also normal. We examined whether her SpO<sub>2</sub> value improved when oxygen was administered in abundance. However, her SpO<sub>2</sub> value remained at 78% under both 5 and 10 L oxygen by mask. On the other hand, under 5 L oxygen, her PaO<sub>2</sub> and SaO<sub>2</sub> values were 230 mmHg and 77.4%, respectively. Thus, we suspected that the patient&#x2019;s condition involved an Hb variant with low oxygen affinity. In fact, the patient had looked pale since adolescence; however, she had no critical symptoms. In addition, the patient&#x2019;s mother also had asymptomatic cyanosis, but she had already died. The patient&#x2019;s son did not have cyanosis. The Hb screening test results were as follows (<xref ref-type="table" rid="t001">Table 1</xref>): both the percentage of HbF and HbA2 were normal; an isopropanol test, which shows the presence of unstable Hb, was within the normal range; the glycerol lysis time was normal and an HbH inclusion body test was negative (ruling out thalassemia); Hb electrophoresis (isoelectric focusing) revealed an abnormal band, at the approximate position of HbA (<xref ref-type="fig" rid="g001">Figure A</xref>). Finally, a DNA sequence analysis of the &#x3B1;- and &#x3B2;-globin genes revealed an AAC to ACC mutation at codon 102 of the &#x3B2;-globin gene, resulting in asparagine to threonine substitution (Hb Kansas) (<xref ref-type="fig" rid="g001">Figure B</xref>).</p>
      <table-wrap id="t001" orientation="portrait" position="float">
        <label>Table 1.</label>
        <caption>
          <p>Hemoglobin Screening Tests Results of the Present Patient.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead style="border-top:solid thin; border-bottom:solid thin;">
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">the present patient</th>
              <th align="center" rowspan="1" colspan="1">normal range</th>
            </tr>
          </thead>
          <tbody style="border-top:solid thin; border-bottom:solid thin;">
            <tr>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">HbF (%)</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">0.5</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">&lt;1.0</td>
            </tr>
            <tr>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">HbA<sub>2</sub> (%)</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">2.5</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">2~3.5</td>
            </tr>
            <tr>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">Isopropanol test</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">(&#xB1;)</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">(-)</td>
            </tr>
            <tr>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">glycerol lysis time (sec)</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">32</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">22~55</td>
            </tr>
            <tr>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">Inclusion body</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">(-)</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">(-)</td>
            </tr>
            <tr>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">Isoelectric focusing</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">Abnormal band (+)</td>
              <td align="center" style="border-bottom:solid thin;" rowspan="1" colspan="1">(-)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="g001" orientation="portrait" position="float">
        <label>Figure.</label>
        <caption>
          <p>A: Hb electrophoresis (isoelectric focusing) of the patient and a control. An abnormal band around the position of HbA was observed in the patient (arrow). B: The direct DNA sequence analysis of the patient&#x2019;s &#x3B2;-globin gene. An AAC to ACC mutation was observed at codon 102 of the &#x3B2;-globin gene. This resulted in an asparagine to threonine substitution.</p>
        </caption>
        <graphic xlink:href="1349-7235-56-0207-g001"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Generally, patients with low SpO<sub>2</sub> and cyanosis may suffer from some cardiopulmonary problems. However, Hb variants with a low oxygen affinity should be considered in patients with unexplained cyanosis, if there is dissociation between PaO<sub>2</sub> and SaO<sub>2</sub> (or SpO<sub>2</sub>). These Hb variants, in which the alteration of the globin structure due to a genetic mutation causes the low oxygen affinity of Hb, are very rare. An increase in the ratio of deoxidized Hb to oxidized Hb can lead to cyanosis. Such patients are otherwise asymptomatic and display slightly decreased Hb levels. The oxygen dissociation curve of these patients is shifted markedly to the right in comparison to healthy controls. The delivery of oxygen to peripheral tissues may be enhanced, resulting in the reduction of erythropoietin-mediated erythropoiesis. In addition to Hb Kansas, Hb Beth Israel (<xref rid="B6" ref-type="bibr">6</xref>) and Hb Saint Mande (<xref rid="B7" ref-type="bibr">7</xref>) are typical Hb variants which display a reduced oxygen affinity, and which lead to cyanosis.</p>
      <p>Since Ishiguro et al. reported the first case of Hb Kansas in a Japanese family (<xref rid="B8" ref-type="bibr">8</xref>), six cases (four lineages), including the case of the present patient, have been reported in Japan (<xref rid="B8" ref-type="bibr">8</xref>-<xref rid="B10" ref-type="bibr">10</xref>) (<xref ref-type="table" rid="t002">Table 2</xref>). Case nos. 1-2 and 3-5 (<xref ref-type="table" rid="t002">Table 2</xref>) were reported from Toyama (mid-west Japan) and Hokkaido (north of Japan) prefecture, respectively. Our patient was from Hokkaido; thus, there were three lineages of Hb Kansas in Hokkaido. However, the relationships among the families were unclear. The patients were diagnosed at various ages (9 to 65 years of age). All of the patients were diagnosed with Hb Kansas based on investigations for asymptomatic cyanosis and family examinations. Hb Kansas patients do not require any specific treatments and their prognosis is good; however patient No. 3 (<xref ref-type="table" rid="t002">Table 2</xref>) who had polycythemia and diabetes mellitus died due to a cerebral infarction.</p>
      <p>The awareness of Hb variants will help ensure a timely diagnosis and avoid unnecessary investigations and managements.</p>
      <table-wrap id="t002" orientation="portrait" position="float">
        <label>Table 2.</label>
        <caption>
          <p>Clinical Data of Hb Kansas Patients Reported in Japan.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead style="border-top:solid thin; border-bottom:solid thin;">
            <tr>
              <th valign="top" align="center" rowspan="1" colspan="1">Patient No.</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Ref.</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Sex</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Age <break/>(year)</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Hb <break/>(g/dL)</th>
              <th valign="top" align="center" rowspan="1" colspan="1">MCV <break/>(fL)</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Reticulocyte <break/>(%)</th>
              <th valign="top" align="center" rowspan="1" colspan="1">SpO<sub>2</sub>
<break/>(%)</th>
              <th valign="top" align="center" rowspan="1" colspan="1">SaO<sub>2</sub>
<break/>(%)</th>
              <th valign="top" align="center" rowspan="1" colspan="1">PaO<sub>2</sub>
<break/>(mmHg)</th>
              <th valign="top" align="center" rowspan="1" colspan="1">comorbidity</th>
            </tr>
          </thead>
          <tbody style="border-top:solid thin; border-bottom:solid thin;">
            <tr>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="center" rowspan="1" colspan="1">F</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">12.4</td>
              <td align="center" rowspan="1" colspan="1">80</td>
              <td align="center" rowspan="1" colspan="1">2.1</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">69</td>
              <td align="center" rowspan="1" colspan="1">101.3</td>
              <td align="center" rowspan="1" colspan="1">none</td>
            </tr>
            <tr>
              <td align="center" rowspan="1" colspan="1">2 </td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="center" rowspan="1" colspan="1">M</td>
              <td align="center" rowspan="1" colspan="1">40</td>
              <td align="center" rowspan="1" colspan="1">14.9</td>
              <td align="center" rowspan="1" colspan="1">94</td>
              <td align="center" rowspan="1" colspan="1">2.1</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">87</td>
              <td align="center" rowspan="1" colspan="1">none</td>
            </tr>
            <tr>
              <td align="center" rowspan="1" colspan="1">(father of 1)</td>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">F</td>
              <td align="center" rowspan="1" colspan="1">62</td>
              <td align="center" rowspan="1" colspan="1">17.7</td>
              <td align="center" rowspan="1" colspan="1">92</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">57.2</td>
              <td align="center" rowspan="1" colspan="1">96.8</td>
              <td align="center" rowspan="1" colspan="1">Polycythemia, DM</td>
            </tr>
            <tr>
              <td align="center" rowspan="1" colspan="1">4 </td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">F</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">12.5</td>
              <td align="center" rowspan="1" colspan="1">92</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">60.8</td>
              <td align="center" rowspan="1" colspan="1">100</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
            </tr>
            <tr>
              <td align="center" rowspan="1" colspan="1">(daughter of 3)</td>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="center" rowspan="1" colspan="1">10</td>
              <td align="center" rowspan="1" colspan="1">F</td>
              <td align="center" rowspan="1" colspan="1">57</td>
              <td align="center" rowspan="1" colspan="1">13.7</td>
              <td align="center" rowspan="1" colspan="1">96</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">ND</td>
              <td align="center" rowspan="1" colspan="1">57.3</td>
              <td align="center" rowspan="1" colspan="1">84.6</td>
              <td align="center" rowspan="1" colspan="1">DM</td>
            </tr>
            <tr>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="center" rowspan="1" colspan="1">Present</td>
              <td align="center" rowspan="1" colspan="1">F</td>
              <td align="center" rowspan="1" colspan="1">65</td>
              <td align="center" rowspan="1" colspan="1">13.9</td>
              <td align="center" rowspan="1" colspan="1">90</td>
              <td align="center" rowspan="1" colspan="1">1.1</td>
              <td align="center" rowspan="1" colspan="1">70</td>
              <td align="center" rowspan="1" colspan="1">58.1</td>
              <td align="center" rowspan="1" colspan="1">88.7</td>
              <td align="center" rowspan="1" colspan="1">Dyslipidemia, HT</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>MCV: mean corpuscular volume, SpO<sub>2</sub>: oxygen saturation by pulse oximetry, SaO<sub>2</sub>: arterial oxygen saturation, PaO<sub>2</sub>: arterial partial pressure of oxygen, ND: not described, DM: diabetes mellitus, HT: hypertension</p>
            <p>Note: SpO<sub>2</sub>, SaO<sub>2</sub>, and PaO<sub>2</sub> were all measured under room air</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>The authors state that they have no Conflict of Interest (COI).</title>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgement</title>
      <p>We thank Fumiya Takagi and Masafumi Kimoto (Fukuyama Medical Laboratory Co., Ltd.) for performing the Hb analysis.</p>
    </ack>
    <ref-list>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hardison</surname><given-names>RC</given-names></name>, <name><surname>Chui</surname><given-names>DH</given-names></name>, <name><surname>Giardine</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server</article-title>. <source>Hum Mutat</source>
<volume>19</volume>: <fpage>225</fpage>-<lpage>233</lpage>, <year>2002</year>.<pub-id pub-id-type="pmid">11857738</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verhovsek</surname><given-names>M</given-names></name>, <name><surname>Henderson</surname><given-names>MP</given-names></name>, <name><surname>Cox</surname><given-names>G</given-names></name>, <name><surname>Luo</surname><given-names>HY</given-names></name>, <name><surname>Steinberg</surname><given-names>MH</given-names></name>, <name><surname>Chui</surname><given-names>DH</given-names></name></person-group>
<article-title>Unexpectedly low pulse oximetry measurements associated with variant hemoglobins: A systematic review</article-title>. <source>Am J Hematol</source>
<volume>85</volume>: <fpage>882</fpage>-<lpage>885</lpage>, <year>2010</year>.<pub-id pub-id-type="pmid">20890907</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reissmann</surname><given-names>KR</given-names></name>, <name><surname>Ruth</surname><given-names>WE</given-names></name>, <name><surname>Nomura</surname><given-names>T</given-names></name></person-group>
<article-title>A human hemoglobin with lowered oxygen affinity and impaired heme-heme interactions</article-title>. <source>J Clin Invest</source>
<volume>40</volume>: <fpage>1826</fpage>-<lpage>1833</lpage>, <year>1961</year>.<pub-id pub-id-type="pmid">14491349</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bonaventura</surname><given-names>J</given-names></name>, <name><surname>Riggs</surname><given-names>A</given-names></name></person-group>
<article-title>Hemoglobin Kansas, a human hemoglobin with a neutral amino acid substitution and an abnormal oxygen equilibrium</article-title>. <source>J Biol Chem</source>
<volume>243</volume>: <fpage>980</fpage>-<lpage>991</lpage>, <year>1968</year>.<pub-id pub-id-type="pmid">5640981</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gibson</surname><given-names>QH</given-names></name>, <name><surname>Riggs</surname><given-names>A</given-names></name>, <name><surname>Imamura</surname><given-names>T</given-names></name></person-group>
<article-title>Kinetic and equilibrium properties of Hemoglobin Kansas</article-title>. <source>J Biol Chem</source>
<volume>248</volume>: <fpage>5976</fpage>-<lpage>5986</lpage>, <year>1973</year>.<pub-id pub-id-type="pmid">4726294</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagel</surname><given-names>RL</given-names></name>, <name><surname>Lynfield</surname><given-names>J</given-names></name>, <name><surname>Johnson</surname><given-names>J</given-names></name>, <name><surname>Landau</surname><given-names>L</given-names></name>, <name><surname>Bookchin</surname><given-names>RM</given-names></name>, <name><surname>Harris</surname><given-names>MB</given-names></name></person-group>
<article-title>Hemoglobin Beth Israel. A mutant causing clinically apparent cyanosis</article-title>. <source>N Engl J Med</source>
<volume>29</volume>: <fpage>125</fpage>-<lpage>130</lpage>, <year>1976</year>.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arous</surname><given-names>N</given-names></name>, <name><surname>Braconnier</surname><given-names>F</given-names></name>, <name><surname>Thillet</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Hemoglobin Saint Mande beta 102 (G4) asn replaced by tyr: a new low oxygen affinity variant</article-title>. <source>FEBS Lett</source>
<volume>126</volume>: <fpage>114</fpage>-<lpage>116</lpage>, <year>1981</year>.<pub-id pub-id-type="pmid">7238856</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishiguro</surname><given-names>K</given-names></name>, <name><surname>Ohba</surname><given-names>Y</given-names></name>, <name><surname>Hattori</surname><given-names>Y</given-names></name>, <etal>et al</etal></person-group>
<article-title>Hemoglobin Kansas in a Japanese family</article-title>. <source>Hemoglobin</source>
<volume>7</volume>: <fpage>573</fpage>-<lpage>579</lpage>, <year>1983</year>.<pub-id pub-id-type="pmid">6668189</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morita</surname><given-names>K</given-names></name>, <name><surname>Fukuzawa</surname><given-names>J</given-names></name>, <name><surname>Onodera</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Hemoglobin Kansas in a patient with polycythemia</article-title>. <source>Ann Hematol</source>
<volume>65</volume>: <fpage>229</fpage>-<lpage>231</lpage>, <year>1992</year>.<pub-id pub-id-type="pmid">1457581</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>Y</given-names></name>, <name><surname>Tsutsumi</surname><given-names>Y</given-names></name>, <name><surname>Nakata</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Blood gas analysis suggested the abnormality of hemoglobin and resulted to diagnose of the unstable hemoglobin disease (Hb Kansas) for a cyanosis patient</article-title>. <source>Hakodate Igaku Shi</source>
<volume>31</volume>: <fpage>21</fpage>-<lpage>23</lpage>, <year>2007</year> (in Japanese).</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
